{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:16:22Z","timestamp":1793798182102,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K17031"],"award-info":[{"award-number":["JP19K17031"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.parkreldis.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T13:04:58Z","timestamp":1620738298000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-2340","authenticated-orcid":false,"given":"Keita","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Ii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Tabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-7212","authenticated-orcid":false,"given":"Maki","family":"Umino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3077-7262","authenticated-orcid":false,"given":"Hidehiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-4943","authenticated-orcid":false,"given":"Akihiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Tomimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.05.002_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.wnr.0000227984.84927.a7","article-title":"Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease","volume":"17","author":"Sasaki","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/WNR.0b013e328315a637","article-title":"Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications","volume":"19","author":"Sasaki","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00234-013-1199-9","article-title":"Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies","volume":"55","author":"Kitao","year":"2013","journal-title":"Neuroradiology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ene.12838","article-title":"Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease","volume":"23","author":"Reim\u00e3o","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000350291","article-title":"Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy","volume":"70","author":"Matsuura","year":"2013","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00234-013-1171-8","article-title":"3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease","volume":"55","author":"Ogisu","year":"2013","journal-title":"Neuroradiology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","article-title":"Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging","volume":"20","author":"Ohtsuka","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/mds.26201","article-title":"Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease","volume":"30","author":"Castellanos","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2017.08.029","article-title":"Quantitative susceptibility mapping differentiates between parkinsonian disorders","volume":"44","author":"Sj\u00f6str\u00f6m","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib11","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3174\/ajnr.A4412","article-title":"Nigrosome 1 Detection at 3T MRI for the diagnosis of early-stage idiopathic Parkinson disease: assessment of diagnostic accuracy and agreement on imaging asymmetry and clinical laterality","volume":"36","author":"Noh","year":"2015","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib12","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.3389\/fneur.2019.01158","article-title":"Low pulvinar intensity in susceptibility-weighted imaging may suggest cognitive worsening after deep brain stimulation therapy in patients with Parkinson's disease","volume":"10","author":"Matsuura","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00702-017-1688-9","article-title":"Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease","volume":"124","author":"Hatano","year":"2017","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib14","article-title":"Correction to: the diagnostic value of SNpc using NM-MRI in Parkinson\u2019s disease: meta-analysis","volume":"40","author":"Wang","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2016.09.011","article-title":"A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease","volume":"633","author":"Matsuura","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis, Mov","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Disord"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11598540-000000000-00000","article-title":"Drug-induced parkinsonism in the elderly: Incidence, management and prevention","volume":"29","author":"L\u00f3pez-Sendn","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear gaze palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/mds.26919","article-title":"Essential pitfalls in \u201cessential\u201d tremor","volume":"32","author":"Espay","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/ene.12341","article-title":"EFNS\/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood","volume":"21","author":"Van de Warrenburg","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib24","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib25","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/mds.27365","article-title":"Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease","volume":"33","author":"Taniguchi","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib26","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/mds.27502","article-title":"Life span pigmentation changes of the substantia nigra detected by neuromelanin-sensitive MRI","volume":"33","author":"Xing","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2463\/mrms.5.197","article-title":"Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla","volume":"5","author":"Shibata","year":"2006","journal-title":"Magn. Reson. Med. Sci."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/neup.12590","article-title":"Chameleons and mimics: progressive supranuclear palsy and corticobasal degeneration","volume":"40","author":"Mimuro","year":"2020","journal-title":"Neuropathology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2169\/internalmedicine.2553-18","article-title":"Symptomatic characteristics of Parkinson's disease induced by neuroleptic drugs, based on a functional neuroimaging diagnosis","volume":"59","author":"Tachibana","year":"2020","journal-title":"Intern. Med."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria, Mov","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Disord"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bpa.12168","article-title":"The brainstem pathologies of PD and DLB","volume":"20","author":"Seidel","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.1124","article-title":"Corticobasal syndrome with tau pathology","volume":"16","author":"Cordato","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib33","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3174\/ajnr.A3567","article-title":"Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and123I-metaiodobenzylguanidine scintigraphy","volume":"34","author":"Miyoshi","year":"2013","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.parkreldis.2021.05.002_bib34","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00234-020-02479-9","article-title":"Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease","volume":"62","author":"Nakata","year":"2020","journal-title":"Neuroradiology"},{"key":"10.1016\/j.parkreldis.2021.05.002_bib35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"Office of rare diseases neuropathologic criteria for corticobasal degeneration","volume":"61","author":"Dickson","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:22:20Z","timestamp":1761178940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021001656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":35,"alternative-id":["S1353802021001656"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.002","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}